Clinical trials
Coronary Disease clinical trials
Below are recruiting coronary disease clinical trials, each written for real people, not researchers. We’re tracking 680 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06205810Recruiting
Complete study on heart artery blockages
This trial looks at people with a blockage in a heart artery of 50% or more. It tests a new way to check the blockage using a special CT scan. This could help decide the best treatment to prevent future heart problems.
Aalst, Oost-VlaanderenAges 18 years+ - NCT06179212Recruiting
Comparing exercise tests for men and women with heart disease
This study compares two different exercise test methods to see which works better for men and women with heart disease. The goal is to find a test that can help doctors design better exercise programs for you.
Ottawa, OntarioAges 18 years+ - NCT06170541Recruiting
Comparing heart artery scans for coronary disease
This study tests whether a newer CT scan method can better detect coronary heart disease. You may qualify if your doctor referred you for a heart CT scan.
Baltimore, MarylandAges 21–85 - NCT04440761Recruiting
Registry for people with MINOCA heart-related chest pain
This is a research registry that collects information from people diagnosed with MINOCA (a specific type of heart-related injury). It may help researchers better understand causes and outcomes for this condition.
LondonAges 16 years+ - NCT05981911Recruiting
Study of Xience Skypoint stents in everyday heart care
This trial is checking how well Xience Skypoint stents work and how safe they are for people who need them to open blocked heart arteries. It's for patients getting these stents as part of their normal treatment.
SeoulAges 19 years+ - NCT04679740Recruiting
Magnesium stent used in routine care registry study
This is a registry study that follows people who receive a resorbable magnesium scaffold (a temporary artery support used during procedures). The goal is to learn how the device performs and how patients do over time in real-world use.
CairnsAges 18 years+ - NCT05704296Recruiting
Two bypass techniques using leg vein and chest artery
This study compares two ways of using a leg vein and an artery from your chest during coronary artery bypass surgery. It may help doctors learn which approach works best for making the new blood pathways to your heart.
SeoulAges 19 years+ - NCT05681702RecruitingPhase 4
Personalizing medicines to reduce bleeding after stent procedure
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
Jacksonville, FloridaAges 18 years+ - NCT05618353RecruitingPhase 4
Colchicine before surgery to lower heart and inflammation complications
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
Birmingham, AlabamaAges 18 years+ - NCT05461729Recruiting
Testing a heart rehab timing prediction tool after a heart attack
This study follows people with coronary artery disease who are starting a structured heart rehabilitation program after a heart attack or heart procedures. The trial tests whether it can predict and improve the right timing or planning for cardiac rehab.
Ennepetal, North Rhine-WestphaliaAges 18 years+ - NCT05487612Recruiting
MiECC heart-lung machine vs standard bypass during heart surgery
This trial compares a newer heart-lung machine setup (MiECC) with the usual bypass technique during certain heart operations. It may help see whether MiECC changes outcomes like the need for blood transfusions or recovery after surgery.
TorontoAges 18–85 - NCT05418556RecruitingPhase 4
Comparing antiplatelet strategies after heart stent
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
Bucheon-siAges 19 years+ - NCT05427370Recruiting
Compare bypass or stent treatment in weak heart patients
This study compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stent procedure (PCI)—in people with a weak pumping heart. It looks at which approach works best when the heart muscle is not pumping well and there are multiple blocked heart arteries.
Los Angeles, CaliforniaAges 18 years+ - NCT05427084RecruitingPhase 2/Phase 3
Canagliflozin to reduce inflammation in heart artery disease
This trial tests canagliflozin to see if it lowers “vascular inflammation” in people with diabetes and stable coronary artery disease. It may help reduce harmful inflammation signals that can raise future heart risk.
Ottawa, OntarioAges 18 years+ - NCT05369442Recruiting
Blood-thinner plan study for people with high bleeding risk after PCI
This trial studies which blood-thinner (antiplatelet) strategy is safest and most effective for people at high risk of bleeding after a procedure called PCI. It also looks at longer-term outcomes and whether adjusting treatment can improve safety without losing heart protection.
Sichuan, SichuanAges Any age - NCT05325034Recruiting
Lipid-lowering plan after heart attack in adults
This study tests a cholesterol-lowering treatment plan for adults admitted for a Type 1 heart attack. It may help your care team choose guideline-based cholesterol goals and treatments after the event.
Wollongong, New South WalesAges 18 years+ - NCT05332262Recruiting
Study to predict heart damage risk during planned angioplasty
This trial focuses on people with stable coronary artery disease who are scheduled for planned angioplasty (PCI). It looks for a “precision medicine” approach to identify who may be at risk for a small heart injury around the procedure, so doctors can better prevent it.
Jacksonville, FloridaAges 18 years+ - NCT02038660Recruiting
Drug-coated balloon treatment registry for narrowed blood vessels
This study records outcomes for people who get a drug-coated balloon used to treat a narrowed blood vessel after a first balloon treatment. It may help doctors understand how well this approach works in everyday care and for different patient needs.
Bucheon-siAges 20 years+ - NCT05100940Recruiting
Study after a heart procedure complication
This trial looks at what happens after complications during or after a heart procedure called coronary angiography or PCI. It may help improve care and outcomes for people who experience a problem during treatment.
Minneapolis, MinnesotaAges 18 years+ - NCT05111288Recruiting
Testing a pulse field therapy for reduced heart ischemia
This trial studies whether pulse electromagnetic field therapy can improve signs of reduced blood flow to the heart (ischemia) in people who cannot or will not get a coronary procedure during the study. If you already take standard heart medicines, you may be eligible to add this therapy and undergo exercise testing and heart imaging.
Scottsdale, ArizonaAges 18 years+ - NCT02039752Recruiting
Registry for adults with multi-vessel heart disease
This study is a registry that collects information about adults with heart disease affecting more than one vessel. It may help doctors better understand how these conditions are managed over time at Asan Medical Center.
SeoulAges 19 years+ - NCT01788592Recruiting
Study of drug-coated stents in routine heart procedure care
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
SeoulAges 18 years+ - NCT04604782RecruitingPhase 1/Phase 2
Regadenoson study in children to test safety and dosing
This trial tests how safe regadenoson is in children and how the body handles it after dosing. It also uses a heart “stress test” with MRI (CMR) when doctors feel it’s needed.
ParisAges 4 weeks–18 years - NCT04443530Recruiting
Testing Ultimaster stents in everyday patient care
This trial looks at how safe and effective two specific stents are when doctors use them as part of routine care. You may be a candidate if you’re an adult receiving one of these Ultimaster stents and can follow the study check-in schedule.
ChuncheonAges 19 years+
Hear when a new Coronary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coronary disease?
- Yes. Clin2 currently lists 680 recruiting coronary disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coronary disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coronary disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.